POLYVALENT ANTIVENIN IN THE TREATMENT OF EXPERIMENTAL SNAKE VENOM POISONING

[1] Andrews E. H., 1953, Journal of the Florida Medical Association, V40, P388

[2] Githens TS, 1939, J IMMUNOL, V37, P47

[3] Githens TS, 1929, J IMMUNOL, V16, P71

[4] HUTCHISON R. H., 1929, BULL ANTIVENIN INST AMERICA, V3, P43

[5] JACKSON D, 1944, CLINICAL TROPICAL ME, P881

[6] JACKSON DUDLEY, 1929, SOUTHERN MED JOUR, V22, P605, DOI 10.1097/00007611-192907000-00002

[7] MINTON SA, 1953, COPEIA, V4, P212

[8] SCHOTTLER W H, 1952, Bull World Health Organ, V5, P293

[9] SCHOTTLER WHA, 1951, AM J TROP MED, V31, P500

[10] SCHOTTLER WHA, 1951, AM J TROP MED, V31, P836

[1] Andrews E. H., 1953, Journal of the Florida Medical Association, V40, P388

[2] Githens TS, 1939, J IMMUNOL, V37, P47

[3] Githens TS, 1929, J IMMUNOL, V16, P71

[4] HUTCHISON R. H., 1929, BULL ANTIVENIN INST AMERICA, V3, P43

[5] JACKSON D, 1944, CLINICAL TROPICAL ME, P881

[6] JACKSON DUDLEY, 1929, SOUTHERN MED JOUR, V22, P605, DOI 10.1097/00007611-192907000-00002

[7] MINTON SA, 1953, COPEIA, V4, P212

[8] SCHOTTLER W H, 1952, Bull World Health Organ, V5, P293

[9] SCHOTTLER WHA, 1951, AM J TROP MED, V31, P500

[10] SCHOTTLER WHA, 1951, AM J TROP MED, V31, P836